Advanced search
Publication Cover
Current Medical Research and Opinion Volume 33, 2017 - Issue 4
Submit an article Journal homepage
654
Views
10
CrossRef citations to date
0
Altmetric
Diabetes

A randomized clinical trial of the safety and efficacy of sitagliptin in patients with type 2 diabetes mellitus inadequately controlled by acarbose alone

Weiqing WangRuijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China;
,
Guang NingRuijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China;
,
Jianhua MaNanjing First Hospital Affiliated to Nanjing Medical University, Nanjing, China;
,
Xiaomin LiuThe First Affiliated Hospital of Harbin Medical University, Heilongjiang, China;
,
Shaoxiong ZhengThe Second Hospital of Tianjin Medical University, Tianjin, China;
,
Fan WuMerck & Co., Inc., Kenilworth, NJ, USA; ;Current address: Roche (China) Holding Ltd., Beijing, China;
,
Lei XuMerck & Co., Inc., Kenilworth, NJ, USA;
,
Edward A. O’NeillMerck & Co., Inc., Kenilworth, NJ, USA;
,
Kenji P. FujitaMerck & Co., Inc., Kenilworth, NJ, USA; ;Current address: Alexion Pharmaceuticals, New Haven, CT, USA
,
Samuel S. EngelMerck & Co., Inc., Kenilworth, NJ, USA;
,
Keith D. KaufmanMerck & Co., Inc., Kenilworth, NJ, USA;
&
R. Ravi ShankarMerck & Co., Inc., Kenilworth, NJ, USA; Correspondence[email protected]
 show all
Pages 693-699 | Received 23 Aug 2016, Accepted 21 Dec 2016, Published online: 25 Jan 2017

References

  • Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311-21
  • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53
  • UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65
  • Karter AJ, Moffet HH, Liu J, et al. Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry. Am J Manag Care 2005;11:262-70
  • Narayan KM, Gregg EW, Fagot-Campagna A, et al. Diabetes – a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract 2000;50(Suppl 2):S77-S84
  • He K, Shi JC, Mao XM. Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients. Ther Clin Risk Manag 2014;10:505-11
  • Derosa G, Maffioli P. alpha-Glucosidase inhibitors and their use in clinical practice. Arch Med Sci 2012;8:899-906
  • Plosker GL. Sitagliptin: a review of its use in patients with type 2 diabetes mellitus. Drugs 2014;74:223-42
  • Drucker DJ. The biology of incretin hormones. Cell Metab 2006;3:153-65
  • Engel SS, Round E, Golm GT, et al. Safety and tolerability of sitagliptin in type 2 diabetes: pooled analysis of 25 clinical studies. Diabetes Ther 2013;4:119-45
  • Zhan M, Xu T, Wu F, Tang Y. Sitagliptin in the treatment of type 2 diabetes: a meta- analysis. J Evid Based Med 2012;5:154-65
  • Kurozumi A, Okada Y, Mori H, et al. Efficacy of alpha-glucosidase inhibitors combined with dipeptidyl-peptidase-4 inhibitor (alogliptin) for glucose fluctuation in patients with type 2 diabetes mellitus by continuous glucose monitoring. J Diabetes Investig 2013;4:393-8
  • Kishimoto M, Noda M. A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers. Cardiovasc Diabetol 2011;10:115
  • Tajima N, Kadowaki T, Okamoto T, et al. Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes. J Diabetes Investig 2013;4:595-604
  • Aoki K, Kamiyama H, Yoshimura K, et al. Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin. Acta Diabetol 2012;49:225-30
  • Aoki K, Masuda K, Miyazaki T, et al. Effects of miglitol, sitagliptin or their combination on plasma glucose, insulin and incretin levels in non-diabetic men. Endocr J 2010;57:667-72
  • Ueno H, Tsuchimochi W, Wang HW, et al. Effects of miglitol, acarbose, and sitagliptin on plasma insulin and gut peptides in type 2 diabetes mellitus: a crossover study. Diabetes Ther 2015;6:187-96
  • Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70
  • Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med 1985;4:213-26
  • Mohan V, Yang W, Son HY, et al. Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea. Diabetes Res Clin Pract 2009;83:106-16
  • Yang W, Guan Y, Shentu Y, et al. The addition of sitagliptin to ongoing metformin therapy significantly improves glycemic control in Chinese patients with type 2 diabetes. J Diabetes 2012;4:227-37

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.